The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 30, 2023

Filed:

Nov. 01, 2017
Applicant:

Kyoto University, Kyoto, JP;

Inventors:

Tasuku Honjo, Kyoto, JP;

Kenji Chamoto, Kyoto, JP;

Fumihiko Matsuda, Kyoto, JP;

Yasushi Okuno, Kyoto, JP;

Sidonia Fagarasan, Saitama, JP;

Assignee:

Kyoto University, Kyoto, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/49 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 16/28 (2006.01); G01N 33/50 (2006.01); A61P 31/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 33/492 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); G01N 33/5011 (2013.01); G01N 33/6872 (2013.01); G01N 2800/52 (2013.01); G01N 2800/7028 (2013.01);
Abstract

The present invention provides markers for judging the efficacy of therapy with a PD-1 signal inhibitor before or at an early stage of the therapy. As biomarkers for predicting or judging the efficacy of therapy with a PD-1 signal inhibitor, surrogate indicators of metabolic changes relating to mitochondrial activity in T cells and/or T cell activation in a subject are used. As such indicators, intestinal flora-related metabolites in the serum or plasma, energy metabolism-related metabolites in the serum or plasma, amino acid metabolism-related metabolites and/or derivatives thereof in the serum of plasma, oxygen consumption rate and/or ATP turnover in peripheral blood CD8cells, amino acids in T cells, and T-bet in peripheral blood CD8cells may be used.


Find Patent Forward Citations

Loading…